 A Multicenter, double blind, randomized trial in which each volunteer will receive one of 2 dose concentrations of one of two lots of Aventis Pasteur Smallpox Vaccine as a single vaccination undiluted, 1:5 dilution. Volunteers without a take at day 7 - 9 will be offered a vaccination with Dryvax at the end of the study. 